These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

198 related articles for article (PubMed ID: 26857693)

  • 1. Symposium Summary: "Breathe In, Breathe Out, Its Easy: What You Need to Know About Developing Inhaled Drugs".
    Tepper JS; Kuehl PJ; Cracknell S; Nikula KJ; Pei L; Blanchard JD
    Int J Toxicol; 2016 Jul; 35(4):376-92. PubMed ID: 26857693
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Pediatric in vitro and in silico models of deposition via oral and nasal inhalation.
    Carrigy NB; Ruzycki CA; Golshahi L; Finlay WH
    J Aerosol Med Pulm Drug Deliv; 2014 Jun; 27(3):149-69. PubMed ID: 24870701
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A case series on lung deposition analysis of inhaled medication using functional imaging based computational fluid dynamics in asthmatic patients: effect of upper airway morphology and comparison with in vivo data.
    Vinchurkar S; Backer LD; Vos W; Holsbeke CV; Backer JD; Backer WD
    Inhal Toxicol; 2012; 24(2):81-8. PubMed ID: 22260527
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The in vitro and in vivo investigation of a novel small chamber dry powder inhalation delivery system for preclinical dosing to rats.
    Sellers S; Horodnik W; House A; Wylie J; Mauser P; Donovan B
    Inhal Toxicol; 2015; 27(13):706-16. PubMed ID: 26452700
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The impact of pulmonary diseases on the fate of inhaled medicines--a review.
    Wang YB; Watts AB; Peters JI; Williams RO
    Int J Pharm; 2014 Jan; 461(1-2):112-28. PubMed ID: 24291124
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The relevance of animal models for aerosol studies.
    Phalen RF; Oldham MJ; Wolff RK
    J Aerosol Med Pulm Drug Deliv; 2008 Mar; 21(1):113-24. PubMed ID: 18518837
    [TBL] [Abstract][Full Text] [Related]  

  • 7. iBCS: 3. A Biopharmaceutics Classification System for Orally Inhaled Drug Products.
    Hastedt JE; Bäckman P; Cabal A; Clark A; Ehrhardt C; Forbes B; Hickey AJ; Hochhaus G; Jiang W; Kassinos S; Kuehl PJ; Prime D; Son YJ; Teague S; Tehler U; Wylie J
    Mol Pharm; 2024 Jan; 21(1):164-172. PubMed ID: 38059771
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Computational Models of Inhalation Therapy in Early Childhood: Therapeutic Aerosols in the Developing Acinus.
    Katan JT; Hofemeier P; Sznitman J
    J Aerosol Med Pulm Drug Deliv; 2016 Jun; 29(3):288-98. PubMed ID: 26907858
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Inhaled aerosol particle dosimetry in mice: a review.
    Méndez LB; Gookin G; Phalen RF
    Inhal Toxicol; 2010 Oct; 22(12):1032-7. PubMed ID: 20879957
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A combined experimental and numerical study on upper airway dosimetry of inhaled nanoparticles from an electrical discharge machine shop.
    Tian L; Shang Y; Chen R; Bai R; Chen C; Inthavong K; Tu J
    Part Fibre Toxicol; 2017 Jul; 14(1):24. PubMed ID: 28701167
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Challenges in inhaled product development and opportunities for open innovation.
    Forbes B; Asgharian B; Dailey LA; Ferguson D; Gerde P; Gumbleton M; Gustavsson L; Hardy C; Hassall D; Jones R; Lock R; Maas J; McGovern T; Pitcairn GR; Somers G; Wolff RK
    Adv Drug Deliv Rev; 2011; 63(1-2):69-87. PubMed ID: 21144875
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Conference report: 2nd Medicon Valley Inhalation Symposium.
    Lastow O
    Ther Deliv; 2014 Feb; 5(2):119-21. PubMed ID: 24483190
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Pharmacometric Models for Characterizing the Pharmacokinetics of Orally Inhaled Drugs.
    Borghardt JM; Weber B; Staab A; Kloft C
    AAPS J; 2015 Jul; 17(4):853-70. PubMed ID: 25845315
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Perspectives on Lung Dose and Inhaled Biomolecules.
    Wolff RK
    Toxicol Pathol; 2021 Feb; 49(2):378-385. PubMed ID: 32851939
    [TBL] [Abstract][Full Text] [Related]  

  • 15. In vivo-in vitro correlations: predicting pulmonary drug deposition from pharmaceutical aerosols.
    Byron PR; Hindle M; Lange CF; Longest PW; McRobbie D; Oldham MJ; Olsson B; Thiel CG; Wachtel H; Finlay WH
    J Aerosol Med Pulm Drug Deliv; 2010 Dec; 23 Suppl 2():S59-69. PubMed ID: 21133801
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Comparative deposition of inhaled aerosols in experimental animals and humans: a review.
    Schlesinger RB
    J Toxicol Environ Health; 1985; 15(2):197-214. PubMed ID: 3892021
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Toxicologic testing of inhaled pharmaceutical aerosols.
    Wolff RK; Dorato MA
    Crit Rev Toxicol; 1993; 23(4):343-69. PubMed ID: 8155274
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Targeted drug-aerosol delivery in the human respiratory system.
    Kleinstreuer C; Zhang Z; Donohue JF
    Annu Rev Biomed Eng; 2008; 10():195-220. PubMed ID: 18412536
    [TBL] [Abstract][Full Text] [Related]  

  • 19. In vitro, in vivo and ex vivo models for studying particle deposition and drug absorption of inhaled pharmaceuticals.
    Nahar K; Gupta N; Gauvin R; Absar S; Patel B; Gupta V; Khademhosseini A; Ahsan F
    Eur J Pharm Sci; 2013 Aug; 49(5):805-18. PubMed ID: 23797056
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Estimating in vivo airway surface liquid concentration in trials of inhaled antibiotics.
    Hasan MA; Lange CF
    J Aerosol Med; 2007; 20(3):282-93. PubMed ID: 17894535
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.